TAYLOR BINKLEY: Open Payments
NPI 1447980842 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$304 in 9 payments from 7 companies in 2025. Trend: 2023 $376 · 2024 $750 · 2025 $304
Food & beverage: $249Consulting: $40Education: $15
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $125 |
| Invivyd Inc | 2 | $50 |
| ADMA BioManufacturing LLC | 1 | $40 |
| Janssen Biotech, Inc. | 2 | $29 |
| TerSera Therapeutics LLC | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
Products named: UPLIZNA, PEMGARDA, Quzyttir, FASENRA, ENTYVIO, TREMFYA.
Industry payments across TX — which companies pay providers there.
